Literature DB >> 31995442

Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent.

Bin He1, Zhigang Zhang1, Xinyuan Zhang1, Zimin Tang1, Chang Liu2, Zizheng Zheng1, Shaowei Li1,2, Jun Zhang1, Ningshao Xia1,2, Qinjian Zhao1.   

Abstract

Hepatitis E virus (HEV) is responsible for epidemic and sporadic acute hepatitis cases, especially in developing countries. Hepatitis E has become a vaccine-preventable disease in recent years with the development of a licensed vaccine. Most functional and neutralizing monoclonal antibodies (mAbs) are known to be highly sensitive to antigen conformation. In this study, a similar approach was used to characterize the conformational sensitivity of antibodies in human or mouse serum samples. Interestingly, comparative binding analysis using different antigen forms showed that the antibodies in the sera of naturally infected individuals, of human vaccinees and from mice immunized with the HEV p239 vaccine all exhibited a strong preference to particulate antigens over the monomeric form of the truncated capsid protein. The degree of discriminating the two test antigens is similar for serum samples to that for the well-characterized murine mAbs. A functional assay for assessing the inhibition of subviral particle cell entry by antibodies was used to determine the functional titers of anti-HEV antibodies in mouse sera. A good correlation was observed between the functional and binding titers in mouse sera determined using two different methods. This result supports the continued use of the enzyme-linked immunosorbent assay as the primary serological assay assuming that the coating antigen contains conformational and native-like epitopes, as in the case for HEV p239.

Entities:  

Keywords:  Conformational epitope; HEV p239 vaccine; functional assessment; hepatitis E virus; neutralizing antibody; particulate antigen; serological assay

Year:  2020        PMID: 31995442      PMCID: PMC7482910          DOI: 10.1080/21645515.2019.1703454

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  36 in total

1.  Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.

Authors:  Claire Montpellier; Czeslaw Wychowski; Ibrahim M Sayed; Jean-Christophe Meunier; Jean-Michel Saliou; Maliki Ankavay; Anne Bull; André Pillez; Florence Abravanel; François Helle; Etienne Brochot; Hervé Drobecq; Rayan Farhat; Cécile-Marie Aliouat-Denis; Juliano G Haddad; Jacques Izopet; Philip Meuleman; Anne Goffard; Jean Dubuisson; Laurence Cocquerel
Journal:  Gastroenterology       Date:  2017-09-25       Impact factor: 22.682

2.  Multifaceted characterization of recombinant protein-based vaccines: An immunochemical toolbox for epitope-specific analyses of the hepatitis E vaccine.

Authors:  Xin Wang; Min Li; Zhijie Lin; Huirong Pan; Zimin Tang; Zizheng Zheng; Shaowei Li; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Vaccine       Date:  2018-11-02       Impact factor: 3.641

Review 3.  Hepatitis E and pregnancy: current state.

Authors:  María Teresa Pérez-Gracia; Beatriz Suay-García; María Luisa Mateos-Lindemann
Journal:  Rev Med Virol       Date:  2017-03-20       Impact factor: 6.989

4.  Structural basis for the neutralization and genotype specificity of hepatitis E virus.

Authors:  Xuhua Tang; Chunyan Yang; Ying Gu; Cuiling Song; Xiao Zhang; Yingbin Wang; Jun Zhang; Choy Leong Hew; Shaowei Li; Ningshao Xia; J Sivaraman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-03       Impact factor: 11.205

Review 5.  Immunization against Hepatitis E.

Authors:  Bruce L Innis; Julia A Lynch
Journal:  Cold Spring Harb Perspect Med       Date:  2018-11-01       Impact factor: 6.915

6.  A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.

Authors:  Min Zhao; Xiao-Jing Li; Zi-Min Tang; Fan Yang; Si-Ling Wang; Wei Cai; Ke Zhang; Ning-Shao Xia; Zi-Zheng Zheng
Journal:  J Biol Chem       Date:  2015-06-17       Impact factor: 5.157

7.  Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods.

Authors:  Xiaochen Yin; Xin Wang; Zhigang Zhang; Yufang Li; Zhijie Lin; Huirong Pan; Ying Gu; Shaowei Li; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  J Pharm Biomed Anal       Date:  2019-09-13       Impact factor: 3.935

Review 8.  Hepatitis E virus: Current epidemiology and vaccine.

Authors:  Xing Wu; Pan Chen; Huijuan Lin; Xiaotian Hao; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2016-05-16       Impact factor: 3.452

9.  An Optimized High-Throughput Neutralization Assay for Hepatitis E Virus (HEV) Involving Detection of Secreted Porf2.

Authors:  Chang Liu; Wei Cai; Xin Yin; Zimin Tang; Guiping Wen; Charuta Ambardekar; Xinlei Li; Dong Ying; Zongdi Feng; Zizheng Zheng; Ningshao Xia
Journal:  Viruses       Date:  2019-01-15       Impact factor: 5.048

Review 10.  Molecular Biology and Infection of Hepatitis E Virus.

Authors:  Yuchen Nan; Yan-Jin Zhang
Journal:  Front Microbiol       Date:  2016-09-07       Impact factor: 5.640

View more
  2 in total

1.  Ehrlichia chaffeensis and E. canis hypothetical protein immunoanalysis reveals small secreted immunodominant proteins and conformation-dependent antibody epitopes.

Authors:  Tian Luo; Jignesh G Patel; Xiaofeng Zhang; David H Walker; Jere W McBride
Journal:  NPJ Vaccines       Date:  2020-09-11       Impact factor: 9.399

2.  Immunoreactive Protein Repertoires of Ehrlichia chaffeensis and E. canis Reveal the Dominance of Hypothetical Proteins and Conformation-Dependent Antibody Epitopes.

Authors:  Tian Luo; Jignesh G Patel; Xiaofeng Zhang; David H Walker; Jere W McBride
Journal:  Infect Immun       Date:  2021-08-02       Impact factor: 3.609

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.